We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 18, 2020

Biomarker-Driven Therapies for Previously Treated Squamous NSCLC

The Lancet Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Oncology
Biomarker-Driven Therapies for Previously Treated Squamous Non-Small-Cell Lung Cancer (Lung-MAP SWOG S1400): A Biomarker-Driven Master Protocol
Lancet Oncol 2020 Oct 27;[EPub Ahead of Print], MW Redman, VA Papadimitrakopoulou, K Minichiello, FR Hirsch, PC Mack, LH Schwartz, E Vokes, S Ramalingam, N Leighl, J Bradley, J Miao, J Moon, L Highleyman, C Miwa, ML LeBlanc, S Malik, VA Miller, EV Sigal, S Adam, D Wholley, C Sigman, B Smolich, CD Blanke, K Kelly, DR Gandara, RS Herbst

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading